Any current/future new fundraising through debt or equity?

There is no explicit mention of any current or immediate future fundraising through debt or equity in the provided transcript. The company recently raised funds through QIP proceeds amounting to INR 8,798 million, which were fully utilized for repayment of borrowings and funding working capital. A preferential allotment of INR 2,000 million was also made to enhance financial position. The management indicated a disciplined approach to managing financial obligations and highlighted a healthy cash balance of INR 3,605 million. Capex plans totaling around INR 300 crores are to be spent judiciousl

Any current/future capex/capital investment/strategic investment?

Planned capex of roughly INR 300 crores including Hi-Tech plants. Current strategy is to optimize production facilities and increase capacity without immediate heavy capex. Aim to leverage existing assets before committing significant investments. Not in a hurry to spend the full INR 300 crores; expected to be spent judiciously over 3-5 years. No major growth capex planned for existing RHI Magnesita India plants (Bhiwadi, Vizag, Cuttack). Recent expansions at Vizag (INR 55-60 crores spent last year) and Cuttack (expanded from 18kt to 30kt capacity). Focus on optimizing production footprint (e.

Future growth expectations in sales/revenue/volumes?

Industry expected to experience robust growth driven by steel, cement, glass, non-ferrous sectors. Growth supported by government infrastructure initiatives and budget policies. Company focusing on both organic and inorganic growth strategies to meet rising demand. Acquisitions of DOCL and Hi-Tech Chemicals expand production capacity and diversify product portfolio. Integration synergies improving revenue and EBITDA margins. Capacity optimization and planned capex of ~INR300 crores over 3-5 years to improve production without rushed spending. Efforts to increase in-house manufacturing (current

Future growth expectations in earnings/operating earnings/profits/EPS?

The company targets sustainable EBITDA margins around 14%-15% on a consolidated basis, acknowledging challenges especially due to lower margins from acquisitions like Dalmia. (Page 11) Management aims to increase EBITDA margins over the medium term through synergies from acquisitions and growth in higher-margin segments like flow control, which showed margin improvement from 15.8% to 20%. (Page 6) Revenue growth is expected between INR 4,000 to 4,500 crores for FY24, though softening steel prices and price reductions may impact the top line adversely. (Page 6) Refractory Management Services (R

RHI Magnesita India LtdQ1 FY24Industrial Products

RHI Magnesita India Ltd Q1 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹361.4P/E: 39.9Market Cap: ₹7.5K CrSector: Industrial Products

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Yes

Order

N/A

Capex

1 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

Industry expected to experience robust growth driven by steel, cement, glass, non-ferrous sectors.
Growth supported by government infrastructure initiatives and budget policies.
Company focusing on both organic and inorganic growth strategies to meet rising demand.
Acquisitions of DOCL and Hi-Tech Chemicals expand production capacity and diversify product portfolio.
Integration synergies improving revenue and EBITDA margins.
Capacity optimization and planned capex of ~INR300 crores over 3-5 years to improve production without rushed spending.
Efforts to increase in-house manufacturing (currently 76% of sales volume) aiming to reduce outsourcing gradually.
Refractory Management Services (RMS) business growing; currently 31% of consolidated revenue.
Exports expected to increase gradually from current 11%.
Conservative revenue forecast for FY24 around INR4,000+ crores despite price pressures; volume growth expected to support topline.

Margin guidance

Category 3

The company targets sustainable EBITDA margins around 14%-15% on a consolidated basis, acknowledging challenges especially due to lower margins from acquisitions like Dalmia. (Page 11)
Management aims to increase EBITDA margins over the medium term through synergies from acquisitions and growth in higher-margin segments like flow control, which showed margin improvement from 15.8% to 20%. (Page 6)
Revenue growth is expected between INR 4,000 to 4,500 crores for FY24, though softening steel prices and price reductions may impact the top line adversely. (Page 6)
Refractory Management Services (RMS) business, contributing 31% of revenues consolidated, is targeted for growth, which typically carries better than normal supply margins, providing margin stability. (Page 14)
Capex focused on optimizing existing capacities with INR 300 crore planned over 3-5 years, emphasizing margin improvement before large spend. (Page 9)
Management maintains a disciplined approach to balancing growth and margin expansion with ongoing customer support and contract negotiations to manage price pressures. (Page 15)

See what RHI Magnesita India Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

Yes

There is no explicit mention of any current or immediate future fundraising through debt or equity in the provided transcript.
The company recently raised funds through QIP proceeds amounting to INR 8,798 million, which were fully utilized for repayment of borrowings and funding working capital.
A preferential allotment of INR 2,000 million was also made to enhance financial position.
The management indicated a disciplined approach to managing financial obligations and highlighted a healthy cash balance of INR 3,605 million.
Capex plans totaling around INR 300 crores are to be spent judiciously over 3-5 years, with no urgent need for additional debt or equity mentioned.
No specific plans for new fundraising via debt or equity were discussed or indicated in this call.

Order book

The transcript provided on pages 14-15 does not contain specific details about the current or expected order book or pending orders for RHI Magnesita India Limited. The discussion primarily covers aspects such as long-term contracts, pricing negotiations, capacity utilization, margins, and financial performance. Key points related to order visibility and contracts: - Long-term contracts are typically for three years with annual price negotiations based on certain formulas. - The company emphasizes stronger relationships with customers supporting mutual adjustments as needed. - Sole-supplier contracts (e.g., with Sunflag for 22 years) provide assured volumes and reduce competition. - There is no explicit quantitative data provided about the current or expected order book or pending orders in the transcript. If you need a detailed breakdown of the order book, it is not available in this transcript.

See what RHI Magnesita India Ltd management said on order book — free account, 30 seconds.

Capex plans

Planned capex of roughly INR 300 crores including Hi-Tech plants.
Current strategy is to optimize production facilities and increase capacity without immediate heavy capex.
Aim to leverage existing assets before committing significant investments.
Not in a hurry to spend the full INR 300 crores; expected to be spent judiciously over 3-5 years.
No major growth capex planned for existing RHI Magnesita India plants (Bhiwadi, Vizag, Cuttack).
Recent expansions at Vizag (INR 55-60 crores spent last year) and Cuttack (expanded from 18kt to 30kt capacity).
Focus on optimizing production footprint (e.g., shifting production closer to demand centers to gain margin synergies).
Emphasis on increasing local manufacturing and reducing outsourcing gradually over the next 3-4 years.

Track RHI Magnesita India Ltd — get its next earnings analysis in your feed

How does RHI Magnesita India Ltd rank vs peers in Industrial Products?

Pro feature

ThisRHI Magnesita India Ltd

Rev 3Mar 3

See where RHI Magnesita India Ltd sits in Industrial ProductsSee which companies these are, and every other name in the sector.Open rankings

How does RHI Magnesita India Ltd rank in Industrial Products?

Compare RHI Magnesita India Ltd against every Industrial Products company (Q1 FY24) on revenue, margins and earnings-call signals.

View Industrial Products leaderboard →

What RHI Magnesita India Ltd's management said in earlier quarters

Others in Industrial Products this season

Gallantt Ispat Ltd. (Q2 FY27)
13,311.13 Lakhs (~13.15% increase) . Key results statement takeaways from Gallantt Ispat Ltd.'s Q2 FY27 results statement — and how it ranks against sector peer
Lead Reclaim and Rubber Products Ltd (Q2 FY26)
Revenue from Operations for H1 FY26: ₹2,190 lakhs, up 138.04% YoY (from ₹920 lakhs in H1 FY25) (Page 19) . Key investor presentation takeaways from Lead Reclaim
Shubhshree Biofuels Energy Ltd (Q2 FY26)
Revenue from operations for H1 FY26: ₹9,604.6 Lakhs . Key investor presentation takeaways from Shubhshree Biofuels Energy Ltd's Q2 FY26 investor presentation —
De Neers Tools (Q2 FY26)
H1FY26 Net Sales:** ₹670.4 Mn . Key investor presentation takeaways from De Neers Tools's Q2 FY26 investor presentation — and how it ranks against sector peers.

Compare:vs Cummins India vs Polycab India vs Welspun Corp Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

RHI Magnesita India Ltd Q1 FY24 Earnings Call Analysis

Revenue guidance

Fundraise plans

Capex plans

How does RHI Magnesita India Ltd rank in Industrial Products?

Continue your research

What RHI Magnesita India Ltd's management said in earlier quarters

Others in Industrial Products this season